HeartSciences Inc.
HSCS
$3.05
$0.0852.87%
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 149.15% | 830.00% | 257.69% | 100.00% | -41.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 149.15% | 830.00% | 257.69% | 100.00% | -41.00% |
| Cost of Revenue | 100.00% | 662.50% | 117.86% | 48.78% | -45.24% |
| Gross Profit | 180.56% | 941.67% | 420.83% | 135.85% | -40.00% |
| SG&A Expenses | 5.59% | 3.01% | -5.88% | 14.15% | 12.21% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 28.65% | 17.52% | 3.37% | -7.05% | -7.61% |
| Operating Income | -28.53% | -17.25% | -3.15% | 7.20% | 7.55% |
| Income Before Tax | -25.20% | -18.58% | -3.95% | 5.66% | 8.72% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -25.20% | -18.58% | -3.95% | 5.66% | 8.72% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -25.20% | -18.58% | -3.95% | 5.66% | 8.72% |
| EBIT | -28.53% | -17.25% | -3.15% | 7.20% | 7.55% |
| EBITDA | -28.53% | -17.25% | -3.15% | 7.21% | 7.63% |
| EPS Basic | 82.68% | 64.26% | 57.80% | 61.65% | 58.17% |
| Normalized Basic EPS | 82.68% | 64.26% | 57.81% | 61.65% | 58.17% |
| EPS Diluted | 82.68% | 64.26% | 57.80% | 61.65% | 58.17% |
| Normalized Diluted EPS | 82.68% | 64.26% | 57.81% | 61.65% | 58.17% |
| Average Basic Shares Outstanding | 635.75% | 470.19% | 341.99% | 233.56% | 91.41% |
| Average Diluted Shares Outstanding | 635.75% | 470.19% | 341.99% | 233.56% | 91.41% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
